Search Prime Grants

UH3HL151297

Cooperative Agreement

Overview

Grant Description
Reducing asthma attacks in disadvantaged school children with asthma - Project summary/abstract

Our re-submission proposal, "Reducing Asthma Attacks in Disadvantaged School Children with Asthma," seeks broad-scale implementation of our effective school-based approach to improve asthma disparities for children in low-income communities (ages 5 to 12 years). Using community-based participatory methods with high-risk populations and communities, we will contextualize dissemination and implementation (D&I) of our Colorado School-Based Asthma Program (COL-SBAP) that reduces asthma exacerbations and missed school days, while also addressing social determinants of health (SDOH) which our pilot identified as major drivers of asthma disparities.

We will evaluate key metrics identified by diverse stakeholders during a dissemination trial in rural and small metropolitan areas of Colorado. Our dissemination trial will include two interventions: our evidence-based COL-SBAP and an evidence-based assessment and management approach to key SDOH. Our pilot data show both interventions are critical to improve asthma disparities for children from low-income families.

This two-step level of intervention, called Stop Asthma Attacks (SAA), will be designed for sustainable delivery by school asthma navigators and school nurses who coordinate with primary care and community resources. In partnership with our community stakeholders, the Exploration, Preparation, Implementation, Sustainment (EPIS) D&I framework will be applied during the UG3 planning phase to iteratively adapt our current implementation guide to tailored implementation plans that meet local community and site-specific needs, resources, and priorities (EPIS Phases 1 & 2).

We will then conduct a UH3 dissemination trial with a randomized stepped-wedge study design in asthma "hot spot" school systems across five Colorado regions to evaluate implementation strategies across asthma "hot spot" school systems (EPIS Phase 3, UH3 trial) and to apply the work from EPIS Phases 1-3 to develop a "dissemination playbook" to guide future program adoption by other school systems (EPIS Phase 4).

The central hypothesis is that SAA will have broad and equitable reach (primary outcome), and yield important benefits in reducing asthma attacks and symptoms, as compared to schools that have not yet implemented SAA. The SAA playbook will be designed to promote the sustainable adoption of SAA, including training materials and a calculation of return on investment.

Our proposal is responsive to and addresses key elements of NHLBI HL-20-003 by "testing late-stage (T4) implementation research strategies" and "promoting and improving population health in high-burden communities" by using a public health approach to target "hot spot" schools with high levels of uncontrolled asthma and asthma-associated burden.

This proposal will both include a rigorous stakeholder engagement process to ensure SAA is disseminated to diverse geopolitical areas of Colorado with attention to sustainability. Collectively, this evaluation and playbook will accelerate dissemination of SAA nationally to communities experiencing health inequities in pediatric asthma care.
Funding Goals
NOT APPLICABLE
Place of Performance
Aurora, Colorado 800457106 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 246% from $1,035,629 to $3,579,519.
The Regents Of The Univ. Of Colorado was awarded Stop Asthma Attacks (SAA) for Disadvantaged School Children Cooperative Agreement UH3HL151297 worth $3,579,519 from National Heart Lung and Blood Institute in September 2020 with work to be completed primarily in Aurora Colorado United States. The grant has a duration of 7 years and was awarded through assistance program 93.837 Cardiovascular Diseases Research. The Cooperative Agreement was awarded through grant opportunity Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 9/5/25

Period of Performance
9/10/20
Start Date
8/31/27
End Date
72.0% Complete

Funding Split
$3.6M
Federal Obligation
$0.0
Non-Federal Obligation
$3.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UH3HL151297

Subgrant Awards

Disclosed subgrants for UH3HL151297

Transaction History

Modifications to UH3HL151297

Additional Detail

Award ID FAIN
UH3HL151297
SAI Number
UH3HL151297-2064884711
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
MW8JHK6ZYEX8
Awardee CAGE
0P6C1
Performance District
CO-06
Senators
Michael Bennet
John Hickenlooper

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) Health research and training Grants, subsidies, and contributions (41.0) $1,035,629 100%
Modified: 9/5/25